Anti-androgen therapy for triple-negative breast cancer may benefit lower-androgen tumors -- ScienceDaily

"Results showed that not only does anti-androgen receptor therapy reduce the ability of androgen-receptor-expressing triple-negative breast cancers to proliferate, migrate and invade, but for these cells, androgen receptor seems essential to survival. When Barton and colleagues blocked androgen receptor in these cells, the cells died."



Read full story: Anti-androgen therapy for triple-negative breast cancer may benefit lower-androgen tumors -- ScienceDaily